Alvotech Files 6-K Report
Ticker: ALVOW · Form: 6-K · Filed: Mar 18, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Alvotech filed a 6-K, confirming 20-F annual reports. Standard procedure.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on March 18, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech files its annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Why It Matters
This filing confirms Alvotech's status as a foreign private issuer and its reporting schedule with the SEC, providing transparency for investors.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 20250318 (date) — Filing Date
- 9, Rue de Bitbourg, L-1273 Luxembourg (location) — Principal Executive Office
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the filer?
The filer is Alvotech.
When was this filing made?
The filing was made on March 18, 2025.
Does Alvotech file annual reports under Form 20-F?
Yes, the filing indicates that Alvotech files annual reports under cover of Form 20-F.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 18, 2025 regarding Alvotech (ALVOW).